Aryee DN - Search Results

1

Single-chain antibodies to the EWS NH(2) terminus structurally discriminate between intact and chimeric EWS in Ewing's sarcoma and interfere with the transcriptional activity of EWS in vivo.

Aryee DN, Kreppel M, Bachmaier R, Uren A, Muehlbacher K, Wagner S, Breiteneder H, Ban J, Toretsky JA, Kovar H. Aryee DN, et al. Cancer Res. 2006 Oct 15;66(20):9862-9. doi: 10.1158/0008-5472.CAN-05-4042. Cancer Res. 2006. PMID: 17047047

2

EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.

Ban J, Siligan C, Kreppel M, Aryee D, Kovar H. Ban J, et al. Adv Exp Med Biol. 2006;587:41-52. doi: 10.1007/978-1-4020-5133-3_4. Adv Exp Med Biol. 2006. PMID: 17163154 Review.

3

O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma.

Bachmaier R, Aryee DN, Jug G, Kauer M, Kreppel M, Lee KA, Kovar H. Bachmaier R, et al. Among authors: aryee dn. Oncogene. 2009 Mar 5;28(9):1280-4. doi: 10.1038/onc.2008.484. Epub 2009 Jan 19. Oncogene. 2009. PMID: 19151750 Free PMC article.

4

Frequent low level expression in Ewing sarcoma family tumors and widespread absence of the metastasis suppressor KAI1/CD82 in neuroblastoma.

Aryee DN, Ambros I, Ambros PF, Muehlbacher K, Luegmayr A, Yoshie O, Kovar H. Aryee DN, et al. Pediatr Res. 2002 Aug;52(2):279-85. doi: 10.1203/00006450-200208000-00022. Pediatr Res. 2002. PMID: 12149507

5

Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway.

Spahn L, Petermann R, Siligan C, Schmid JA, Aryee DN, Kovar H. Spahn L, et al. Among authors: aryee dn. Cancer Res. 2002 Aug 15;62(16):4583-7. Cancer Res. 2002. PMID: 12183411

6

Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein.

Spahn L, Siligan C, Bachmaier R, Schmid JA, Aryee DN, Kovar H. Spahn L, et al. Among authors: aryee dn. Oncogene. 2003 Oct 9;22(44):6819-29. doi: 10.1038/sj.onc.1206810. Oncogene. 2003. PMID: 14534527

7

EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin.

Siligan C, Ban J, Bachmaier R, Spahn L, Kreppel M, Schaefer KL, Poremba C, Aryee DN, Kovar H. Siligan C, et al. Among authors: aryee dn. Oncogene. 2005 Apr 7;24(15):2512-24. doi: 10.1038/sj.onc.1208455. Oncogene. 2005. PMID: 15735734

8

EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma.

Ban J, Bennani-Baiti IM, Kauer M, Schaefer KL, Poremba C, Jug G, Schwentner R, Smrzka O, Muehlbacher K, Aryee DN, Kovar H. Ban J, et al. Among authors: aryee dn. Cancer Res. 2008 Sep 1;68(17):7100-9. doi: 10.1158/0008-5472.CAN-07-6145. Cancer Res. 2008. PMID: 18757425 Free PMC article.

9

Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro.

Aryee DN, Niedan S, Kauer M, Schwentner R, Bennani-Baiti IM, Ban J, Muehlbacher K, Kreppel M, Walker RL, Meltzer P, Poremba C, Kofler R, Kovar H. Aryee DN, et al. Cancer Res. 2010 May 15;70(10):4015-23. doi: 10.1158/0008-5472.CAN-09-4333. Epub 2010 May 4. Cancer Res. 2010. PMID: 20442286 Free PMC article.

10

Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma.

Ban J, Aryee DN, Fourtouna A, van der Ent W, Kauer M, Niedan S, Machado I, Rodriguez-Galindo C, Tirado OM, Schwentner R, Picci P, Flanagan AM, Berg V, Strauss SJ, Scotlandi K, Lawlor ER, Snaar-Jagalska E, Llombart-Bosch A, Kovar H. Ban J, et al. Among authors: aryee dn. Cancer Res. 2014 Nov 15;74(22):6578-88. doi: 10.1158/0008-5472.CAN-14-1736. Epub 2014 Oct 3. Cancer Res. 2014. PMID: 25281719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters